Abnormal pulmonary function in adults with sickle cell anemia

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 11, 2006, Pages 1264-1269

  Klings, Elizabeth S ^a   Wyszynski, Diego F ^b   Nolan, Vikki G ^b   Steinberg, Martin H ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Airway obstruction; Dyspnea; Restrictive disease

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBON MONOXIDE; CREATININE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE CHEST SYNDROME; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LINEAR REGRESSION ANALYSIS; LIVER DYSFUNCTION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CODING; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SPIROMETRY; THROMBOCYTOSIS; UREA NITROGEN BLOOD LEVEL;

ACUTE DISEASE; ADULT; AGED; ANEMIA, SICKLE CELL; CARBON MONOXIDE; FEMALE; HUMANS; LOGISTIC MODELS; LUNG DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS; RESPIRATORY PHYSIOLOGY;

EID: 33744934804     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200601-125OC     Document Type: Article

References (38)

1. Eaton WA, Hofrichter J. Sickle cell hemoglobin polymerization. Adv Protein Chem 1990;40:63-279. 280.
2. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
3. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003;289:1645-1651.
4. Delclaux C, Zerah-Lancner F, Bachir D, Habibi A, Monin JL, Godeau B, Galacteros F. Factors associated with dyspnea in adult patients with sickle cell disease. Chest 2005;128:3336-3344.
5. Miller GJ, Serjeant GR. An assessment of lung volumes and gas transfer in sickle-cell anaemia. Thorax 1971;26:309-315.
6. Santoli F, Zerah F, Vasile N, Bachir D, Galacteros F, Atlan G. Pulmonary function in sickle cell disease with or without acute chest syndrome. Eur Respir J 1998;12:1124-1129.
7. Leong MA, Dampier C, Varlotta L, Allen JL. Airway hyperreactivity in children with sickle cell disease. J Pediatr 1997;131:278-283.
8. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore) 1988;67:66-76.
9. Girgis RE, Qureshi MA, Abrams J, Swerdlow P. Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement. Am J Hematol 2003;72:177-184.
10. Jaja SI, Opesanwo O, Mojiminivi FB, Kehinde MO. Lung function, haemoglobin and irreversibly sickled cells in sickle cell patients. West Afric J Med 2000;19:225-229.
11. Femi-Pearse D, Gazioglu KM, Yu PN. Pulmonary function studies in sickle cell disease. J Appl Physiol 1970;28:574-577.
12. Machado RF, Gladwin MT. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol 2005;129:449-464.
13. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005;60:206-210.
14. Koumbourlis AC, Zar HJ, Hurlet-Jensen A, Goldberg MR. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. J Pediatr 2001;138:188-192.
15. Sylvester KP, Patey RA, Milligan P, Dick M, Rafferty GF, Rees D, Thein SL, Greenough A. Pulmonary function abnormalities in children with sickle cell disease. Thorax 2004;59:67-70.
16. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991;115:343-349.
17. Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM, Black CM, Coghlan JG. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004;43:461-466.
18. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH. Abnormal pulmonary function in adults with sickle cell disease: association of decreased DlCO with systemic disease [abstract]. In: Abstracts of the American Society of Hematology 47th annual meeting, December 10-13, 2005, Atlanta, Georgia, USA. Blood 2005;106:316a.
19. Gaston M, Smith J, Gallagher D, Flournoy-Gill Z, West S, Bellevue R, Farber M, Grover R, Koshy M, Ritchey AK, et al. Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD). Control Clin Trials 1987;8:131S-140S.
20. Gaston M, Rosse WF. The cooperative study of sickle cell disease: review of study design and objectives. Am J Pediatr Hematol Oncol 1982;4:197-201.
21. CO for hemoglobin concentration. Am J Respir Crit Care Med 1997;155:236-241.
22. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-664.
23. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981;123:185-189.
24. Roberts CM, MacRae KD, Winning AJ, Adams L, Seed WA. Reference values and prediction equations for normal lung function in a nonsmoking white urban population. Thorax 1991;46:643-650.
25. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-1218.
26. Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006;46:105-110.
27. Guasch A, Cua M, Mitch WE. Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int 1996;49:786-791.
28. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology 2005;51-57.
29. Aaron SD, Dales RE, Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 1999;115:869-873.
30. Leong CS, Stark P. Thoracic manifestations of sickle cell disease. J Thorac Imaging 1998;13:128-134.
31. Akinola NO, Stevens SM, Franklin IM, Nash GB, Stuart J. Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol 1992;45:902-906.
32. Milner PF, Joe C, Burke GJ. Bone and joint disease. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven; 1994. pp. 645-661.
33. Silva CM, Viana MB. Growth deficits in children with sickle cell disease. Arch Med Res 2002;33:308-312.
34. Gourgoulianis KI, Molyvdas PA. Growth of thorax in genetic anemias: an index of deficit [letter]. Arch Med Res 2002;33:600.
35. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005;129:465-481.
36. Flaherty KR, Martinez FJ. The role of pulmonary function testing in pulmonary fibrosis. Curr Opin Pulm Med 2000;6:404-410.
37. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516-522.
38. Kato GJ, McGowan VR, Machado RF, Little JA, Taylor VJ, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM Jr, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood 2006;107:2279-2285.